Alterity Therapeutics Limited (PRNAF)
OTCMKTS · Delayed Price · Currency is USD
0.0030
-0.0109 (-78.42%)
At close: Jun 16, 2025
Alterity Therapeutics Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
Cash & Equivalents | 33.16 | 12.64 | 15.77 | 34.81 | 28.12 | Upgrade |
Short-Term Investments | 7.5 | - | - | - | - | Upgrade |
Cash & Short-Term Investments | 40.66 | 12.64 | 15.77 | 34.81 | 28.12 | Upgrade |
Cash Growth | 221.70% | -19.87% | -54.68% | 23.80% | 205.71% | Upgrade |
Accounts Receivable | 3.93 | 4.02 | 8.65 | 4.67 | 4.13 | Upgrade |
Other Receivables | 0.01 | 0.02 | 0.02 | 0.06 | 0.15 | Upgrade |
Receivables | 3.94 | 4.04 | 8.67 | 4.73 | 4.28 | Upgrade |
Prepaid Expenses | 1.23 | 2.32 | 2.57 | 1.6 | 1.09 | Upgrade |
Other Current Assets | 0.04 | 0.04 | 0.04 | 0.01 | 0.01 | Upgrade |
Total Current Assets | 45.87 | 19.04 | 27.05 | 41.14 | 33.49 | Upgrade |
Property, Plant & Equipment | 0.16 | 0.19 | 0.27 | 0.22 | 0.1 | Upgrade |
Total Assets | 46.03 | 19.22 | 27.32 | 41.36 | 33.59 | Upgrade |
Accounts Payable | 0.54 | 0.58 | 1.72 | 2.66 | 1.45 | Upgrade |
Accrued Expenses | 2.89 | 4.56 | 2.5 | 3.02 | 1.56 | Upgrade |
Current Portion of Leases | 0.07 | 0.11 | 0.11 | 0.06 | 0.03 | Upgrade |
Current Income Taxes Payable | 0.02 | 0.02 | 0.03 | 0.03 | - | Upgrade |
Other Current Liabilities | 0.02 | 0.11 | 0.03 | 0.06 | 0.03 | Upgrade |
Total Current Liabilities | 3.53 | 5.37 | 4.38 | 5.82 | 3.07 | Upgrade |
Long-Term Leases | 0.09 | 0.05 | 0.1 | 0.06 | 0.04 | Upgrade |
Other Long-Term Liabilities | - | - | 0.02 | 0.01 | 0.01 | Upgrade |
Total Liabilities | 3.62 | 5.43 | 4.5 | 5.89 | 3.12 | Upgrade |
Common Stock | 262.95 | 223.15 | 213.97 | 213.79 | 197.45 | Upgrade |
Retained Earnings | -225.89 | -214.16 | -195.13 | -181.88 | -169.73 | Upgrade |
Comprehensive Income & Other | 5.34 | 4.81 | 3.97 | 3.57 | 2.75 | Upgrade |
Shareholders' Equity | 42.4 | 13.8 | 22.81 | 35.47 | 30.47 | Upgrade |
Total Liabilities & Equity | 46.03 | 19.22 | 27.32 | 41.36 | 33.59 | Upgrade |
Total Debt | 0.16 | 0.16 | 0.21 | 0.12 | 0.07 | Upgrade |
Net Cash (Debt) | 40.5 | 12.48 | 15.56 | 34.69 | 28.05 | Upgrade |
Net Cash Growth | 224.55% | -19.81% | -55.13% | 23.67% | 206.12% | Upgrade |
Net Cash Per Share | 0.01 | 0.00 | 0.01 | 0.01 | 0.02 | Upgrade |
Filing Date Shares Outstanding | 9,209 | 5,320 | 2,440 | 2,407 | 2,407 | Upgrade |
Total Common Shares Outstanding | 9,127 | 5,245 | 2,440 | 2,407 | 2,084 | Upgrade |
Working Capital | 42.34 | 13.66 | 22.67 | 35.32 | 30.42 | Upgrade |
Book Value Per Share | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | Upgrade |
Tangible Book Value | 42.4 | 13.8 | 22.81 | 35.47 | 30.47 | Upgrade |
Tangible Book Value Per Share | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.